Tandem Diabetes Care, Inc.
NasdaqGM:TNDM
$ 29.54
$-1.16 (-3.78%)
$ 29.54
$-1.16 (-3.78%)
End-of-day quote: 03/11/2024

TNDM - Tandem Diabetes Care Stock Prediction 2025 - 2030

10 years of reliable Tandem Diabetes Care stock forecast. The Wall Street analysts predict Outperform for TNDM. See at a glance whether NasdaqGM:TNDM will rise in the future.

$0.00
Forecast 2023
$35.63
Forecast 2025
$60.56
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$35.63
Forecast 2030
$60.56
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.08
Price-to-book Ratio
6.18
Market Cap
1.91B
TEV
1.86 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$30.80

Tandem Diabetes Care Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Tandem Diabetes Care Stock Forecast 2023

$32.00

In the last five quarters, Tandem Diabetes Care’s Price Target has fallen from $86.06 to $30.80 - a -64.21% decrease. Thridteen analysts predict that Tandem Diabetes Care’s share price will increase in the coming year, reaching $32.00. This would represent an increase of 3.9%.

8.33%
8.33
Last update: 03/12/2024

Highest Price Target $60.00

Average Price Target $32.00

Lowest Price Target $18.00

Tandem Diabetes Care Stock Forecast 2025

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jan 2025.

In Jan 2025 analysts predict a share price of $32.35. An increase of 9.5% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Feb 2025.

In Feb 2025 analysts predict a share price of $32.64. An increase of 10.51% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Mar 2025.

In Mar 2025 analysts predict a share price of $32.94. An increase of 11.52% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Apr 2025.

In Apr 2025 analysts predict a share price of $33.24. An increase of 12.53% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in May 2025.

In May 2025 analysts predict a share price of $33.54. An increase of 13.54% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jun 2025.

In Jun 2025 analysts predict a share price of $33.84. An increase of 14.55% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jul 2025.

In Jul 2025 analysts predict a share price of $34.14. An increase of 15.57% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Aug 2025.

In Aug 2025 analysts predict a share price of $34.44. An increase of 16.58% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Sep 2025.

In Sep 2025 analysts predict a share price of $34.74. An increase of 17.59% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Oct 2025.

In Oct 2025 analysts predict a share price of $35.03. An increase of 18.6% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Nov 2025.

In Nov 2025 analysts predict a share price of $35.33. An increase of 19.61% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Dec 2025.

In Dec 2025 analysts predict a share price of $35.63. An increase of 20.62% compared to today's share price.

Tandem Diabetes Care Stock Predictions 2030

Tandem Diabetes Care Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $54.97. An increase of 86.09% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $55.48. An increase of 87.81% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $55.99. An increase of 89.53% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $56.50. An increase of 91.25% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $57.00. An increase of 92.97% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $57.51. An increase of 94.69% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $58.02. An increase of 96.41% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $58.53. An increase of 98.13% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $59.03. An increase of 99.85% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $59.54. An increase of 101.57% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $60.05. An increase of 103.29% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $60.56. An increase of 105% compared to the previous month's estimate.

P/E
0.00
Beta
1.08
Price-to-book Ratio
6.18
Market Cap
1.91B
TEV
1.86 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$30.80

Tandem Diabetes Care Analyst Ratings Frequently Asked Questions

Who are the analysts watching Tandem Diabetes Care, Inc.?

The following analysts have recently covered Tandem Diabetes Care:

Baird
Barclays
CFRA Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc
Citigroup Inc. Research
Craig-Hallum Capital Group LLC
Lake Street Capital Markets, LLC
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
Stifel
Wells Fargo Securities, LLC
Marktfeld
BofA Global Research
Jefferies LLC
Leerink Partners LLC
Morningstar Inc.
TD Cowen
UBS Investment Bank
Wolfe Research, LLC.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Tandem Diabetes Care, Inc.?

The following sell-side analysts have recently covered Tandem Diabetes Care:

Johnson, Jeffrey D.
Steed, Travis Lee
Bedford, Jayson Tyler
Wuensch, Joanne Karen
Jennings, Joshua Thomas
Nowak, Alexander David
O'Neil, Brooks Gregory
Lichtman, Steven Michael
O'Brien, Matthew Oliver
Blackman, Mathew Justin
Biegelsen, Lawrence H.
Paraskevopoulos, Michail
Miksic, Matthew Stephan
Leon, Kenneth M.
Taylor, Matthew Charles
Kratky, Michael Holden
Wang, Debbie S.
Antalffy, Danielle Joy
Polark, Michael K.
(This information refers to the last 90 days.)